FI43597C - Menetelmä antibioottisen kefalosporinyhdisteen valmistamiseksi - Google Patents

Menetelmä antibioottisen kefalosporinyhdisteen valmistamiseksi

Info

Publication number
FI43597C
FI43597C FI621097A FI109762A FI43597C FI 43597 C FI43597 C FI 43597C FI 621097 A FI621097 A FI 621097A FI 109762 A FI109762 A FI 109762A FI 43597 C FI43597 C FI 43597C
Authority
FI
Finland
Prior art keywords
preparing
cephalosporin compound
antibiotic cephalosporin
antibiotic
compound
Prior art date
Application number
FI621097A
Other languages
English (en)
Other versions
FI43597B (fi
Inventor
Flynn Edwin Harold
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of FI43597B publication Critical patent/FI43597B/fi
Publication of FI43597C publication Critical patent/FI43597C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/26—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group
    • C07D501/34—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group with the 7-amino radical acylated by carboxylic acids containing hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/38—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/38—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
    • C07D501/46—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof with the 7-amino radical acylated by carboxylic acids containing hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Fertilizing (AREA)
  • Shafts, Cranks, Connecting Bars, And Related Bearings (AREA)
FI621097A 1961-06-08 1962-06-04 Menetelmä antibioottisen kefalosporinyhdisteen valmistamiseksi FI43597C (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11561261A 1961-06-08 1961-06-08

Publications (2)

Publication Number Publication Date
FI43597B FI43597B (fi) 1971-02-01
FI43597C true FI43597C (fi) 1971-05-10

Family

ID=22362437

Family Applications (1)

Application Number Title Priority Date Filing Date
FI621097A FI43597C (fi) 1961-06-08 1962-06-04 Menetelmä antibioottisen kefalosporinyhdisteen valmistamiseksi

Country Status (14)

Country Link
BE (1) BE618663A (fi)
BR (1) BR6239733D0 (fi)
CA (1) CA984379A (fi)
CH (1) CH409967A (fi)
DE (2) DE1445701A1 (fi)
DK (1) DK129199B (fi)
ES (1) ES277871A1 (fi)
FI (1) FI43597C (fi)
FR (1) FR2899M (fi)
GB (1) GB982252A (fi)
LU (1) LU41846A1 (fi)
NO (2) NO122749B (fi)
OA (1) OA02701A (fi)
SE (2) SE322513B (fi)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1082943A (en) * 1963-03-27 1967-09-13 Glaxo Lab Ltd Derivatives of 7-aminocephalosporanic acid
US3492297A (en) * 1965-07-01 1970-01-27 Merck & Co Inc Guanidino cephalosporins
GB1195203A (en) * 1966-06-24 1970-06-17 Glaxo Lab Ltd Cephalosporins

Also Published As

Publication number Publication date
GB982252A (en) 1965-02-03
NO122749B (fi) 1971-08-09
DK129199B (da) 1974-09-09
ES277871A1 (es) 1962-12-01
OA02701A (fr) 1970-12-15
DE1445684A1 (de) 1968-12-05
DE1445701A1 (de) 1969-08-28
DK129199C (fi) 1975-01-27
LU41846A1 (fi) 1962-12-07
FR2899M (fr) 1964-11-09
CH409967A (de) 1966-03-31
BE618663A (fr) 1962-12-14
BR6239733D0 (pt) 1973-06-14
NO133074C (fi) 1976-03-03
SE357204B (fi) 1973-06-18
SE322513B (fi) 1970-04-13
NO133074B (fi) 1975-11-24
FI43597B (fi) 1971-02-01
CA984379A (en) 1976-02-24

Similar Documents

Publication Publication Date Title
FI41745C (fi) Tapa valmistaa alfa-amino-oksibentsyyli-penisilliinejä
FI41830C (fi) Menetelmä uusien tetrakosapeptidien valmistamiseksi
FI41029C (fi) Menetelmä antibioottisesti vaikuttavien rifamysiinijohdannaisten valmistamiseksi
FI43597C (fi) Menetelmä antibioottisen kefalosporinyhdisteen valmistamiseksi
FI42331C (fi) Menetelmä alfa-amino-substituoitujen penisilliinien valmistamiseksi
BR6237696D0 (pt) Processo de preparacao de novos compostos de cefalosporin
NL139533B (nl) Werkwijze ter bereiding van derivaten van cefalosporine c.
BR6242365D0 (pt) Processo para a preparacao de antibioticos
FI40886C (fi) Menetelmä antibioottisen aineen kapreomysiinin valmistamiseksi
CA654695A (en) Heterocyclic compounds
CA613856A (en) Machine for manufacturing asbestos-cement tubes
CA646872A (en) Process for preparing lead organic compounds
CA633591A (en) Process for the manufacture of a new antibiotic
FI32677A (fi) Menetelmä heterosyklisen yhdisteen valmistamiseksi
CA626370A (en) Brick-making machine
AU272074B2 (en) Cephalosporin compounds
AU273888B2 (en) Cephalosporin compounds
AU272129B2 (en) Cephalosporin compounds
CA647289A (en) Methods for producing heterocyclic compounds
CA631327A (en) Methods for producing heterocyclic amine compounds
CA613546A (en) Process for knitting
FI37667A (fi) Menetelmä diureettisesti vaikuttavan sulfonyyliamidiyhdisteen valmistamiseksi
AU261991B2 (en) Process for preparing polybasic compounds
CA634820A (en) Process for the manufacture of a new heterocyclic compound
CA621406A (en) P-xylylenediamine salts of penicillin